Tyler-Stone Wealth Management’s Novavax NVAX Stock Holding History

Tyler-Stone Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-744	Closed	-$9.42K	–	728
2024 Q2	$9.42K	Sell	744 -191	-20%	-$1.92K	﹤0.01%	668
2024 Q1	$4.47K	Buy	935 +750	+405%	+$3.48K	﹤0.01%	772
2023 Q4	$888	Hold	185	–	–	﹤0.01%	868
2023 Q3	$1K	Hold	185	–	–	﹤0.01%	871
2023 Q2	$1K	Buy	+185	New	+$1.46K	﹤0.01%	856
2022 Q4	$2K	Buy	185 +46	+33%	+$812	﹤0.01%	761
2022 Q3	$3K	Hold	139	–	–	﹤0.01%	719
2022 Q2	$7K	Buy	139 +52	+60%	+$2.69K	﹤0.01%	613
2022 Q1	$6K	Buy	87 +46	+112%	+$4.1K	﹤0.01%	654
2021 Q4	$6K	Buy	+41	New	+$7.04K	﹤0.01%	681

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Tyler-Stone Wealth Management's NVAX Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Novavax (NVAX) in Q3 2024, closing a stake of 744 shares — an estimated $9.42K sold.

Tyler-Stone Wealth Management first reported a position in NVAX in Q4 2021 and held it in 10 quarters. The position peaked at $9.42K in Q2 2024. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

Tyler-Stone Wealth Management reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
Tyler-Stone Wealth Management sold 744 Novavax shares in Q3 2024, an estimated $9.42K.
Tyler-Stone Wealth Management first reported a position in Novavax in Q4 2021 and held it in 10 quarters.
Tyler-Stone Wealth Management's Novavax position peaked at $9.42K in Q2 2024.
237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.